Boehringer Sues Mylan to Protect Mirapex

Boehringer Ingelheim is suing Mylan for infringing on a patent covering the Parkinson’s disease drug Mirapex. Boehringer filed the suit, Boehringer Ingelheim International GMBH, et al., v. Mylan Pharmaceuticals, Inc., in the U.S. District Court for the District of New Jersey Jan. 26 after Mylan filed an ANDA for a generic 0.75-mg Mirapex (pramipexole dihydrochloride) before the ’812 patent expired.
Generic Line